Switching to marijuana would save smokers a lot
A federal government decision could give you money back and make legal cannabis companies more competitive. So keep pushing your elected officials to push back marijuana dates this fall.
Those are the two key takeaways from this week’s news that the US Department of Health and Human Services has recommended that the Drug Enforcement Administration downgrade cannabis from a Schedule I drug to a Schedule III drug under the Controlled Substances Act.
Cannabis attorney Lauren Mendelsohn of Omar Figueroa Law in Sebastopol, California joins Leafly News Editor-in-Chief David Downs to discuss the news and its implications.
Aside from saving businesses and consumers a bundle of onerous taxes, listing cannabis on Schedule III would likely multiply the scope of cannabis research and cannabinoid medicines worldwide.
Listen to understand what consumers and licensees should do in light of this news and to better understand drug planning and reform policies.
Leafly Senior Editor David Downs is the former cannabis editor of the San Francisco Chronicle. He has appeared on the Today Show and written for Scientific American, The New York Times, WIRED, Rolling Stone, The Onion A/V Club, High Times, and more. He is a judge for the 2023 Emerald Cup and has been involved with weed since 2009.
Check out David Downs articles
Post a comment: